Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer
about
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Beta-adrenergic receptors are expressed across diverse cancers.Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management.Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.
P2860
Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of non-selective β-blocker ...... s in early stage breast cancer
@en
Use of non-selective β-blocker ...... in early stage breast cancer.
@nl
type
label
Use of non-selective β-blocker ...... s in early stage breast cancer
@en
Use of non-selective β-blocker ...... in early stage breast cancer.
@nl
prefLabel
Use of non-selective β-blocker ...... s in early stage breast cancer
@en
Use of non-selective β-blocker ...... in early stage breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Use of non-selective β-blocker ...... s in early stage breast cancer
@en
P2093
Aamer Abbas
Alexa Montoya
Ali Khammanivong
Alireza Torabi
Alok K Dwivedi
Andres Belmont
Brad A Bryan
Clarissa N Amaya
Danielle Liss
Erin B Dickerson
P2860
P304
P356
10.18632/ONCOTARGET.14119
P407
P577
2016-12-23T00:00:00Z